Odd Lot Index

PFIZER INC PFE

Terms unclear

Unclear — read the filing yourself
No closing date could be read from these filings. Nothing has been filed for this offer in over six months, so it is treated as closed — a tender offer cannot run that long. Check the filings below if you think otherwise.
amendment with no indexed original - the original may predate the collection window or may not mention odd lots
StatusClosed (assumed)
Closing datecould not be read; last filing 2013-06-24
How it is priced—
Odd-lot thresholdFewer than 100 shares
Must tender everything you holdYes
Must tick the odd-lot box on the formNot stated

How it finished

Expired2013-06-21
Shares tendered1,680,439,287

Where each of these comes from

Every line above was read out of the filing. Here is the wording it was read from, so you can check it.

must_tender_all = True...the shares of Pfizer common stock that were validly tendered and not validly withdrawn, on a pro rata basis in proportion to the number of shares tendered. Stockholders who owned fewer than 100 shares of Pfizer common stock, or an “odd-lot,” who have validly tendered all of their shares and made the appropriate election will not be subject to proration, in accordance with the terms of the Exchange Offer. Based on the total number of shares of Pfizer common stock reported to be tendered prior to the expiration of the Exchange Offer, it is estimated that approximately 24% of the tendered shares of Pfizer common stock will...
threshold = 100...k owned by Pfizer. Because the Exchange Offer is oversubscribed, Pfizer accepted only a portion of the shares of Pfizer common stock that were validly tendered and not validly withdrawn, on a pro rata basis in proportion to the number of shares tendered. Stockholders who owned fewer than 100 shares of Pfizer common stock, or an “odd-lot,” who have validly tendered all of their shares and made the appropriate election will not be subject to proration, in accordance with the terms of the Exchange Offer. Based on the total number of shares of Pfizer common stock reported to be tendered prior to the expiration of the Exchange Offer, it...
txn_type = TENDER_OFFERSC TO-I/A 1 d556202dsctoia.htm AMENDMENT NO. 4 TO SCHEDULE TO Amendment No. 4 to Schedule TO UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE TO (Amendment No. 4) (Rule 14d-100) TENDER OFFER STATEMENT UNDER SECTION 14(d)(1) OR 13(e)(1) OF THE SECURITIES EXCHANGE ACT OF 1934 PFIZER INC. (Name of Subject Company (Issuer) and Filing Person (Offeror)) Common Stock, $0.05 Par Value (Title of Class of Securities) 717081103 (CUSIP Number of Class of Securities) Amy W. Schulman Executive Vice President and General Counsel Pfizer Inc...
expired_on = 2013-06-21.... Item 4(a) of the Schedule TO, which incorporates by reference the information contained in the Exchange Offer, is hereby amended and supplemented by adding the following thereto: The Exchange Offer expired at 12:00 midnight, New York City time, on June 21, 2013. Under the terms of the Exchange Offer, 0.9898 shares of Zoetis common stock will be exchanged for each share of Pfizer common stock accepted in the Exchange Offer. The Exchange Offer was oversubscribed. According to the exchange agent, Computershare Trust Company, N.A., 1,680,4...
tendered = 1680439287...tock will be exchanged for each share of Pfizer common stock accepted in the Exchange Offer. The Exchange Offer was oversubscribed. According to the exchange agent, Computershare Trust Company, N.A., 1,680,439,287 shares of Pfizer common stock were validly tendered and not validly withdrawn, including 497,530,121 shares that were tendered by notice of guaranteed delivery. Pfizer has accepted 405,117,195 of the tendered shares in exchange for the 400,985,000 shares of Zoetis common stock owned by Pfizer. Because the Exchange Offer is oversu...

The filings

FiledFormRoleOn EDGAR
2013-06-24SC TO-I/Aamendment (governing)View